Management of breast cancer patients with BRCA gene mutations in Lebanon of the Middle East: perspectives and challenges

Hosp Pract (1995). 2021 Dec;49(5):325-329. doi: 10.1080/21548331.2021.1974678. Epub 2021 Sep 22.

Abstract

Background: This commentary explores and discusses the challenges oncologists face in diagnosing and managing breast cancer patients with BRCA gene mutations in Lebanon and the Middle East.

Methods: Key opinion leaders shared their recommendations to achieve better patient outcomes and satisfaction based on evidence-based medicine and their clinical experience in BRCA management.

Results: Challenges associated with BRCA management can be divided into four main levels: physicians, patients, test, and treatment factors. More genetic counselors are to be identified given their important role in the management of individuals with BRCA gene mutations.

Conclusion: Genetic counseling, continuing education, infrastructure, testing, expertise, and financial support are needed to fulfill the unmet needs in the management of BRCA mutation carriers.

Keywords: BRCA mutation; BRCA testing; breast cancer; genetic counseling; mutational analysis; poly ADP ribose polymerase (PARP) inhibitor.

MeSH terms

  • Breast Neoplasms / genetics*
  • Breast Neoplasms / therapy*
  • Evidence-Based Medicine
  • Female
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Humans
  • Lebanon
  • Middle East
  • Women's Health